trial · primary record
Placebo
Covid19
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2027-03 |
| Primary endpoint | Serious Adverse Events |
| Registry ID | NCT04476953 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:40.686Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04476953
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Placebo · compound